First intranasal BCV vaccine ready

First intranasal BCV vaccine ready

MERCK Animal Health announced Oct. 3 the launch of its BOVILIS CORONAVIRUS, the first U.S. Department of Agriculture-approved modified-live intranasal vaccine to aid in the reduction of enteric disease caused by bovine coronavirus (BCV).

Most severe during winter months, BCV is often prevalent in cow/calf beef herds and dairy calves, Merck said, and the virus is frequently diagnosed as the leading pathogen in neonatal calves.

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.